REEM BIOTECHNOLOGY LTD
Executive Summary
Reem Biotechnology Ltd shows a strong balance sheet with significant growth in assets and equity, supported by robust liquidity and no regulatory filing issues. However, the omission of profit and loss details and the rapid increase in fixed assets warrant further financial scrutiny to fully assess operational stability and asset quality. Overall, the company presents a low risk profile based on available data but requires additional due diligence on profitability and governance structure.
View Full Analysis Report →Company Documents
| Date | Description |
|---|---|
| 29/08/2529 August 2025 New | Compulsory strike-off action has been suspended |
| 29/08/2529 August 2025 New | Compulsory strike-off action has been suspended |
| 12/08/2512 August 2025 | First Gazette notice for compulsory strike-off |
| 12/08/2512 August 2025 | First Gazette notice for compulsory strike-off |
| 02/07/242 July 2024 | Registered office address changed from Park Works River Street Heywood OL10 4AB England to Office 34 Phoenix Industrial Estate Failsworth Self Storage Manchester M35 9DS on 2024-07-02 |
| 31/05/2431 May 2024 | Unaudited abridged accounts made up to 2024-01-31 |
| 29/05/2429 May 2024 | Second filing for the appointment of Mr Karl John Rothwell as a director |
| 21/05/2421 May 2024 | Cessation of Karl John Rothwell as a person with significant control on 2024-05-08 |
| 21/05/2421 May 2024 | Termination of appointment of Andrew Charles Smith as a director on 2024-05-08 |
| 21/05/2421 May 2024 | Appointment of Mr Karl John Rothwell as a director on 2024-05-08 |
| 21/05/2421 May 2024 | Appointment of Mr Karl John Rothwell as a director on 2024-05-08 |
| 21/05/2421 May 2024 | Confirmation statement made on 2024-05-21 with updates |
| 21/05/2421 May 2024 | Notification of Karl John Rothwell as a person with significant control on 2024-05-08 |
| 21/05/2421 May 2024 | Notification of Karl John Rothwell as a person with significant control on 2024-05-07 |
| 21/05/2421 May 2024 | Cessation of Lee Taylor as a person with significant control on 2024-05-08 |
| 21/05/2421 May 2024 | Cessation of Andrew Charles Smith as a person with significant control on 2024-05-08 |
| 17/05/2417 May 2024 | Confirmation statement made on 2024-03-10 with no updates |
| 31/01/2431 January 2024 | Annual accounts for year ending 31 Jan 2024 |
| 31/10/2331 October 2023 | Unaudited abridged accounts made up to 2023-01-31 |
| 17/05/2317 May 2023 | Confirmation statement made on 2023-03-10 with updates |
| 17/05/2317 May 2023 | Termination of appointment of Tamer Turker Hassan as a director on 2023-05-10 |
| 28/03/2228 March 2022 | Total exemption full accounts made up to 2022-01-31 |
| 31/01/2231 January 2022 | Annual accounts for year ending 31 Jan 2022 |
| 10/03/2110 March 2021 | APPOINTMENT TERMINATED, DIRECTOR LEE TAYLOR |
| 10/03/2110 March 2021 | CONFIRMATION STATEMENT MADE ON 10/03/21, WITH UPDATES |
| 10/03/2110 March 2021 | DIRECTOR APPOINTED MR TAMER TURKER HASSAN |
| 10/03/2110 March 2021 | APPOINTMENT TERMINATED, SECRETARY AMBER SMITH |
| 26/01/2126 January 2021 | CERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company